Hologic axes expectations as Q4 loss widens
This article was originally published in Clinica
Executive Summary
Hologic’s Q4 was “not the quarter many were hoping for,” said Jefferies’ analyst Raj Denhoy, as it “took the axe to expectations once again with fiscal 2014 and preliminary outer year guidance grossly below expectations.”